Registration summary
ConferenceICOTM
ModeVirtual
ParticipationListener
Registration fee$135.00
Bank charges (5.8%)$7.83
Total payable$142.83
Includes all bank processing charges — the amount above is exactly what will be charged.
Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDG-Aligned Research Themes
ICOTM conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.
01 Advancements in Immunotherapy +
This track will explore the latest breakthroughs in immunotherapy for cancer treatment, focusing on novel approaches and combination therapies. Discussions will include the mechanisms of action, clinical outcomes, and future directions in immunotherapeutic strategies.
02 Precision Medicine in Oncology +
This session will delve into the role of precision medicine in tailoring cancer treatment based on individual genetic profiles. Participants will examine case studies and emerging technologies that enhance personalized therapeutic approaches.
03 Tumor Microenvironment and Biology +
This track will investigate the complex interactions within the tumor microenvironment and their implications for cancer progression and therapy resistance. Emphasis will be placed on cellular and molecular mechanisms that influence tumor biology.
04 Clinical Trials and Innovative Protocols +
This session will highlight the design and implementation of innovative clinical trial protocols in oncology. Key topics will include adaptive trial designs, patient recruitment strategies, and the integration of real-world evidence.
05 Cancer Prevention and Early Detection +
This track will focus on strategies for cancer prevention and the importance of early detection in improving patient outcomes. Discussions will include screening guidelines, risk assessment, and public health initiatives.
06 Health Policy and Cancer Care +
This session will address the impact of health policy on cancer care delivery and access to treatment. Participants will explore policy frameworks, funding mechanisms, and the role of advocacy in shaping oncology practices.
07 Emerging Targets in Cancer Therapy +
This track will examine novel therapeutic targets in cancer biology and their potential for drug development. Discussions will focus on the identification of biomarkers and the translation of laboratory findings into clinical applications.
08 Pediatric Oncology: Challenges and Innovations +
This session will address the unique challenges faced in pediatric oncology, including treatment-related toxicities and long-term survivorship. Innovative approaches to therapy and supportive care will be highlighted.
09 Integrative Approaches in Cancer Treatment +
This track will explore the integration of complementary and alternative medicine in conventional cancer treatment. Emphasis will be placed on evidence-based practices and patient-centered care.
10 Cancer Genomics and Biomarkers +
This session will focus on the role of cancer genomics in identifying biomarkers for diagnosis and treatment. Participants will discuss the implications of genomic data for personalized oncology.
11 Global Perspectives on Oncology Research +
This track will provide a platform for discussing global trends and challenges in oncology research. Participants will share insights on collaborative efforts, resource allocation, and disparities in cancer care worldwide.
